Rosiglitazone use and associated adverse event rates in Canada: an updated analysis
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13104-015-1448-6
Published Online: 2015-09-29
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Iczkovitz, Sandra
Dhalla, Daniella
Terres, Jorge A. Ross